Journal article
Applying biodegradable particles to enhance cancer vaccine efficacy
Immunologic research, Vol.59(1-3), pp.220-228
05/17/2014
DOI: 10.1007/s12026-014-8537-9
PMID: 24838147
Abstract
One of the primary goals of our group and our collaborators here at the University of Iowa is to develop therapeutic cancer vaccines using biodegradable and biocompatible polymer-based vectors. A major advantage of using discretely packaged immunogenic cargo over non-encapsulated vaccines is that they promote enhanced cellular immunity, a key requirement in achieving antitumor activity. We discuss the importance of co-encapsulation of tumor antigen and adjuvant, with specific focus on the synthetic oligonucleotide adjuvant, cytosine–phosphate–guanine oligodeoxynucleotides. We also discuss our research using a variety of polymers including poly(α-hydroxy acids) and polyanhydrides, with the aim of determining the effect that parameters, such as size and polymer type, can have on prophylactic and therapeutic tumor vaccine formulation efficacy. Aside from their role as vaccine vectors per se, we also address the research currently underway in our group that utilizes more novel applications of biodegradable polymer-based particles in facilitating other types of immune-based therapies.
Details
- Title: Subtitle
- Applying biodegradable particles to enhance cancer vaccine efficacy
- Creators
- Kawther K Ahmed - Division of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of IowaSean M Geary - Division of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of IowaAliasger K Salem - Division of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa
- Resource Type
- Journal article
- Publication Details
- Immunologic research, Vol.59(1-3), pp.220-228
- DOI
- 10.1007/s12026-014-8537-9
- PMID
- 24838147
- NLM abbreviation
- Immunol Res
- ISSN
- 0257-277X
- eISSN
- 1559-0755
- Publisher
- Springer US
- Language
- English
- Date published
- 05/17/2014
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Pharmaceutical Sciences and Experimental Therapeutics; Craniofacial Anomalies Research Center; Dental Research; Chemical and Biochemical Engineering
- Record Identifier
- 9984216570202771
Metrics
12 Record Views